CEBP  Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yngveson, A.
Right arrow Articles by Pershagen, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yngveson, A.
Right arrow Articles by Pershagen, G.
Cancer Epidemiology Biomarkers & Prevention Vol. 8, 433-438, May 1999
© 1999 American Association for Cancer Research

p53 Mutations in Lung Cancer Associated with Residential Radon Exposure1

Anna Yngveson2, Cecilia Williams, Anders Hjerpe, Joakim Lundeberg, Peter Söderkvist and Göran Pershagen

Division of Environmental Epidemiology, Institute of Environmental Medicine, Karolinska Institute, S-171 77 Stockholm, [A. Y., G. P.]; Department of Biotechnology, KTH, Royal Institute of Technology, S-10044 Stockholm, [C. W., J. L.]; Department of Immunology, Microbiology, Pathology, and Infectious Diseases, Division of Pathology, Huddinge University Hospital, S-14186 Stockholm, [A. H.]; and Department of Cell Biology, Faculty of Health Sciences, S-58185 Linköping, [P. S.] Sweden

Unusual mutation patterns in lung tumors among underground miners have been indicated, suggesting radon-specific alterations in the genome, but the data are not consistent. To investigate the association between residential radon exposure and p53 mutations in lung tumors, we performed a study on cases from a nation-wide population-based investigation in Sweden. Our study included 83 nonsmoking lung cancer cases and 250 smoking lung cancer cases, diagnosed 1980–1984, with a time-weighted average radon exposure over 140 Bq/m3 or up to 50 Bq/m3. Radon was measured in dwellings occupied by the study subjects at some time since 1947. Information on smoking habits and other risk factors was obtained from questionnaires. After exclusions because of the initiation of treatment or insufficient material, the p53-status of 243 tumors was determined using PCR-single-stranded conformation polymorphism analysis and sequencing determination of exons 5–8. The overall mutation prevalence was 23.9%. An increased mutation prevalence was suggested among those with high exposure to residential radon [odds ratio (OR), 1.4; 95% CI, 0.7–2.6], especially among nonsmokers (OR, 3.2; 95% CI, 0.7–15.5), but no specific mutational pattern was indicated. Furthermore, the mutation prevalence seemed to be higher among smoking lung cancer cases than among nonsmoking cases (OR, 2.1; 95% CI, 0.9–5.0), and particularly among those smoking less than 10 cigarettes per day. It may be concluded that residential exposure to radon seems to contribute to a higher mutation prevalence of the p53 gene in lung tumors.




This article has been cited by other articles:


Home page
Ann OncolHome page
A. Ruano-Ravina, R. Perez-Becerra, M. Fraga, K. T. Kelsey, and J. M. Barros-Dios
Analysis of the relationship between p53 immunohistochemical expression and risk factors for lung cancer, with special emphasis on residential radon exposure
Ann. Onc., January 1, 2008; 19(1): 109 - 114.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
J. M. Barros-Dios, M. A. Barreiro, A. Ruano-Ravina, and A. Figueiras
Exposure to Residential Radon and Lung Cancer in Spain: A Population-based Case-Control Study
Am. J. Epidemiol., September 15, 2002; 156(6): 548 - 555.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. H. Vahakangas, W. P. Bennett, K. Castren, J. A. Welsh, M. A. Khan, B. Blomeke, M. C. R. Alavanja, and C. C. Harris
p53 and K-ras Mutations in Lung Cancers from Former and Never-Smoking Women
Cancer Res., June 1, 2001; 61(11): 4350 - 4356.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
P. Hainaut and G. P. Pfeifer
Patterns of p53 G{->}T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke
Carcinogenesis, March 1, 2001; 22(3): 367 - 374.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Husgafvel-Pursiainen, P. Boffetta, A. Kannio, F. Nyberg, G. Pershagen, A. Mukeria, V. Constantinescu, C. Fortes, and S. Benhamou
p53 Mutations and Exposure to Environmental Tobacco Smoke in a Multicenter Study on Lung Cancer
Cancer Res., June 1, 2000; 60(11): 2906 - 2911.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. Williams, F. Ponten, C. Moberg, P. Soderkvist, M. Uhlen, J. Ponten, G. Sitbon, and J. Lundeberg
A High Frequency of Sequence Alterations Is Due to Formalin Fixation of Archival Specimens
Am. J. Pathol., November 1, 1999; 155(5): 1467 - 1471.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1999 by the American Association for Cancer Research.